Jerry ZHENG is the organization’s Chair for 2026– 2027.
Jerry ZHENG
- Chair of ISPE China Committee; Chiar of ISPE China Digitalization & Artificial Intelligence (AI) CoP
- Managing Director, Körber
ISPE China Committee Members 2026
Shengli HU
- Member of the ISPE China Committee
- VP, Syntegon Packaging Technology
Ping ZHANG, MBA
- Advisory Member of ISPE China Committee
- Senior Vice President of Global Industrial Affairs,Hepalink
Alex WANG
- Member of the ISPE China Committee and Chair of Chemical Drug Production and Process Sub-Committee
- VP,Jiangsu Nhwa Group
Lei FU
- Member of the ISPE China Committee
- Executive Dean,XJTUM
David SUN
- ISPE China Committee Member & the Chair of Manufacturing Engineering Sub-committee
- Head of Preparation Technology, Hepalink Pharmaceutical Group
Hongyang LI
- Member of the ISPE China Committee
- Former VP of TOT BIOPHARM COMPANY LIMITED
Lea DAI
- Member of the ISPE China Committee and Chair of Event Planning Sub-Committee
- Head of Pharmaceutical Technology of Merck Pharmaceuticals
Frank GAO
- Member of the ISPE China Committee and Chair of Gene and Cell Therapy Sub-Committee
- CEO, Beijing PharmGO Consulting
Daniel GAO
- ISPE China Committee Member & the Chair of Pharmaceutical Supply Chain Sub-committee
- CEO, CanPharma
Jimmy LI
- Member of the ISPE China Committee
- CEO of WuXi XDC
Sophie PANG
- ISPE China Committee Member & the Chair of Innovation & Investment Sub-committee
- VP, VBIOSCI
Pete XIE
- Member of the ISPE China Committee and Chair of Training Sub-Committee
- Senior GMPQuality Auditor Beijing Novartis Pharma
Chair of ISPE China Subcommittee 2026
Yutao HUA
- the Chair of ISPE China Regulatory & Compliance Sub-committee
- VP, BiBo Pharma
Sophie PANG
- ISPE China Committee Member & the Chair of Innovation & Investment Sub-committee
- VP, VBIOSCI
Daniel GAO
- ISPE China Committee Member & the Chair of Pharmaceutical Supply Chain Sub-committee
- CEO, CanPharma
Lea DAI
- Member of the ISPE China Committee and Chair of Event Planning Sub-Committee
- Head of Pharmaceutical Technology of Merck Pharmaceuticals
David SUN
- ISPE China Committee Member & the Chair of Manufacturing Engineering Sub-committee
- Head of Preparation Technology, Hepalink Pharmaceutical Group
Alex WANG
- Member of the ISPE China Committee and Chair of Chemical Drug Production and Process Sub-Committee
- VP,Jiangsu Nhwa Group
Fuchang YANG
- Chair of ISPE China GEP CoP
- VP, Wiskind
Wei KANG
- Chair of ISPE China Project Design & Event Mgt subcommittee
- VP of Austar
Jerry ZHENG
- Chair of ISPE China Committee; Chiar of ISPE China Digitalization & Artificial Intelligence (AI) CoP
- Managing Director, Körber
Lynn ZHANG
- Chair of ISPE China WIP subcommittee
- Pharma Vertical Head, Strategic Sales Dept. Honeywell Building Automation
June WANG
- Chair of ISPE China GAMP CoP
- Senior CSV Expert, Head of GMP,Siemens China
Raymond ZHANG
- Co-Chair of ISPE China GAMP CoP
- Sr. manager IT Automation Department Novo Nordisk China
Huilin ZHU
- Chair of Biological Drug Product and Process Sub-Committee
- Head of Clinical Manufacturing, WuXi Biologics
Bin NI
- Chair of ISPE China Sustainability CoP
- GM,Pharmaceutical BU,CEFOC
ISPE Shanghai is led by the Board of Directors.
ISPE Shanghai Board of Directors

Ping ZHANG, MBA
- Advisory Member of ISPE China Committee
- Senior Vice President of Global Industrial Affairs,Hepalink

Mike Martin
- President and CEO
- ISPE

Shanshan Liu
- Technical Director
- No Deviation Pte Ltd

Jerry ZHENG
- Chair of ISPE China Committee; Chiar of ISPE China Digitalization & Artificial Intelligence (AI) CoP
- Managing Director, Körber

Mark Hernick
- Director |
- Chief Operating Officer of ISPE

















制药有限公司-IT自动化部高级经理-张睿1.png)



